Thursday, March 13, 2025 10:20:02 AM
Eli Lilly owns close to 20% of the company and their funded through 2027 IP Patents = BULLET PROOF
they get bought by LLY or ALNY for 1.5-2 Billion in the next 24 months or less
IP is bullet proof for oligonucleotide editing space they will receive royalties from others in the space.
Only small cap with 100x if they decide not to sell their soon to be conglomerate funded through 2027 with Lily starting to pay them on 3.9 Billion partnership in place with PRQR
This reminds me of Horizon Therapeutics sold for 28 Billion and Stock price history for Horizon Therapeutics (HZNP). Highest end of day price: $119.91 USD on 2021-10-29. Lowest end of day price: $1.99 USD on 2013-03-04.
Similar Story PRQR CEO has a son with a rare disease like Horizons PRQR is backed by the most powerful biotech company in the world LLY & the king of RNAI Alnylam what a great fit PRQR would be for either powerhouse.
RNA editing for 30 Indications
All founders from ALNY on the PRQR board
$PRQR
Recent PRQR News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/09/2026 01:07:21 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/06/2026 09:01:11 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/20/2026 10:21:56 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2026 01:08:44 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/06/2025 12:00:20 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/03/2025 09:01:51 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/20/2025 10:00:32 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2025 11:00:15 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/26/2025 08:41:20 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/03/2025 08:11:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2025 11:00:17 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/01/2025 12:07:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/14/2025 11:08:19 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/25/2025 08:37:50 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
